The estimated penetrance of ovarian cancer by age 70 years was 21.5% (95% CI: 10.4-37.0%) for BRCA1 mutation carriers and 7.3% for BRCA2 mutation carriers. The gene discussed is BRCA1; the disease is ovarian carcinoma.